I A Global Asset Management Inc. Morphic Holding, Inc. Transaction History

I A Global Asset Management Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2023 Nov 15, 2023	SELL	$21.33 - $59.42 $103,237 - $287,592	-4,840 Reduced 9.58%	45,680 $1.05 Million
Q2 2023 Aug 14, 2023	BUY	$34.33 - $62.11 $1.73 Million - $3.14 Million	50,520 New	50,520 $2.9 Million

140

38.7M

4.2K

200K

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of I A Global Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on I A Global Asset Management Inc. with notifications on news.